BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/17/2017 6:29:40 AM | Browse: 1266 | Download: 1705
 |
Received |
|
2016-10-24 17:07 |
|
Peer-Review Started |
|
2016-10-28 10:24 |
|
To Make the First Decision |
|
2016-12-01 09:07 |
|
Return for Revision |
|
2016-12-01 10:24 |
|
Revised |
|
2016-12-30 02:45 |
|
Second Decision |
|
2017-01-10 17:02 |
|
Accepted by Journal Editor-in-Chief |
|
2017-01-13 05:30 |
|
Accepted by Company Editor-in-Chief |
|
2017-01-18 10:02 |
|
Articles in Press |
|
2017-01-18 10:02 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-05-12 15:52 |
|
Publish the Manuscript Online |
|
2017-05-17 06:29 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bastian Neesgaard, Morten Ruhwald and Nina Weis |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Amagar and Hvidovre Hospital Research Foundation of 45000 Dkr. |
to Bastian Neesgaard |
| Family Hede Nielsen Foundation of 10000 Dkr. |
to Bastian Neesgaard |
|
| Corresponding Author |
Nina Weis, MD, PhD, Associate Professor, Department of Infectious Diseases, Copenhagen University Hospital Hvidovre, Kettegårds allé 30, 2650 Hvidovre, Denmark. nina.weis@regionh.dk |
| Key Words |
Chronic hepatitis C; Inducible protein-10’s; Sustained virological response; Interferon-γ-inducible protein-10; CXCL-10; Chemokine; Genotype; Pegylated interferon; Ribavirin; Rapid virological response |
| Core Tip |
This is the first systematic review examining the association between baseline levels of interferon-γ-inducible protein-10 (IP-10) and virological response to treatment with pegylated interferon and ribavirin among patients chronically infected with hepatitis C virus, genotype 1-4. We found a possible correlation for genotype 1 and 4 infected patients, indicating that baseline IP-10 levels could predict which patients, infected with genotype 1 or 4, would have the highest likelihood of benefitting from antiviral treatment with pegylated interferon and ribavirin. These findings can be especially relevant in countries, where treatments with direct acting antivirals are not readily applicable. |
| Publish Date |
2017-05-17 06:29 |
| Citation |
Neesgaard B, Ruhwald M, Weis N. Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review. World J Hepatol 2017; 9(14): 677-688 |
| URL |
http://www.wjgnet.com/1948-5182/full/v9/i14/677.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v9.i14.677 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
